Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marilyn D. Olson"'
Autor:
Claude Darte, Marilyn D. Olson, Fred S. Apple, Stephen L. Chan, Denise Uettwiller-Geiger, Alan H.B. Wu, David L. Woodrum, Anthony W. Jevans, Sean Roberts, Per Venge
Publikováno v:
Clinical Chemistry. 48:869-876
Background: Cardiac troponin I (cTnI) is a powerful tool to aid in the diagnosis of myocardial infarction and cardiac muscle damage. We describe an assay that overcomes problems of early assays that were often affected by cTnI degradation, assay inte
Autor:
Show-Hong Duh, Fred S. Apple, Kristin Mascotti, Robert T. McCormack, Robert H. Christenson, David L. Morgan, Gladys L. Alonsozana, Joseph H. Keffer, Frank H. Wians, Marilyn D. Olson
Publikováno v:
Clinical Chemistry. 44:52-60
We evaluated the ACCESS® cardiac troponin I (cTnI) immunoassay as a marker for myocardial infarction (MI). Total imprecision was 6.0% to 13.5%, the minimum detectable concentration was 0.007 μg/L, and the limit of quantitation was 0.046 μg/L. Comp
Autor:
Denise, Uettwiller-Geiger, Alan H B, Wu, Fred S, Apple, Anthony W, Jevans, Per, Venge, Marilyn D, Olson, Claude, Darte, David L, Woodrum, Sean, Roberts, Stephen, Chan
Publikováno v:
Clinical chemistry. 48(6 Pt 1)
Cardiac troponin I (cTnI) is a powerful tool to aid in the diagnosis of myocardial infarction and cardiac muscle damage. We describe an assay that overcomes problems of early assays that were often affected by cTnI degradation, assay interference, po